Filing Details

Accession Number:
0001144204-15-031430
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-15 15:20:33
Reporting Period:
2015-02-24
Filing Date:
2015-05-15
Accepted Time:
2015-05-15 15:20:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410098 Cormedix Inc. CRMD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1368953 Antony Pfaffle C/O Cormedix Inc.
745 Route 202-206, Suite 303
Bridgewater NJ US 08807
Interim Chief Medical Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Disposition 2015-05-13 4,722 $6.49 12,003 No 4 S Direct
Common Stock, $0.001 Par Value Per Share Disposition 2015-05-14 12,003 $6.49 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock, $0.001 Par Value Per Share Stock Option (right to buy) $2.27 2024-04-01 100,000 100,000 Direct
Common Stock, $0.001 Par Value Per Share Stock Option (right to buy) $2.02 2024-01-09 100,000 100,000 Direct
Common Stock, $0.001 Par Value Per Share Stock Option (right to buy) $2.02 2024-01-09 30,000 30,000 Direct
Common Stock, $0.001 Par Value Per Share Stock Option (right to buy) $0.90 2023-03-22 210,000 210,000 Direct
Common Stock, $0.001 Par Value Per Share Stock Option (right to buy) $0.68 2022-12-05 250,000 250,000 Direct
Common Stock, $0.001 Par Value Per Share Stock Option (right to buy) $0.29 2022-01-06 30,000 30,000 Direct
Common Stock, $0.001 Par Value Per Share Stock Option (right to buy) $2.10 2021-01-14 30,000 30,000 Direct
Common Stock, $0.001 Par Value Per Share Stock Option (right to buy) $3.13 2020-03-30 20,000 20,000 Direct
Common Stock, $0.001 Par Value Per Share Stock Option (right to buy) $5.00 2025-02-24 75,000 75,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-04-01 100,000 100,000 Direct
2024-01-09 100,000 100,000 Direct
2024-01-09 30,000 30,000 Direct
2023-03-22 210,000 210,000 Direct
2022-12-05 250,000 250,000 Direct
2022-01-06 30,000 30,000 Direct
2021-01-14 30,000 30,000 Direct
2020-03-30 20,000 20,000 Direct
2025-02-24 75,000 75,000 Direct
Footnotes
  1. The options vested 100% on April 2, 2014
  2. The options vested 100% on January 10, 2014.
  3. The options vest in full on the first anniversary of the date of grant.
  4. These options vest based on performance milestones running through December 31, 2014.
  5. These options vested as follows: (a) fifty percent (50%) on the date of the issuance of the CE mark certification, which occurred on July 5th, 2013, and (b) fifty percent (50%) on December 31, 2013.
  6. These options vested on January 14, 2012.
  7. These options vested as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.
  8. These options were granted on February 24, 2015, and vested immediately.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.31 to $6.65, inclusive.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.34 to $6.70, inclusive.